Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Publication year range
1.
Clin Rehabil ; 11(3): 253-62, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9360039

ABSTRACT

OBJECTIVES: To describe the routing through the health care system and the level of functioning of a consecutive series of lower limb amputees at a general Dutch hospital. METHODS: A descriptive cohort study (medical records examination) with a follow-up interval of 11.7 months. All 124 major lower limb amputations (ankle to hip) between 1 July 1989 and 31 December 1992 are included in the study: 123 patients, average age 73.8 years, 96% vascular disease. Amputation levels are 55.3% transfemoral, 12.2% knee disarticulation and 32.5% transtibial. At follow-up two patients are missing. RESULTS: Before admission to hospital 75.6% of patients are able to walk and 79.9% live independently. Discharge destinations from hospital are 22.5% home, 42.3% inpatient rehabilitation and 32.4% nursing home. At follow-up, 59% of surviving patients have a prosthesis, 47.7% are able to walk and 70.5% live independently. Mortality after one year is 28.5%. Poor preoperative walkers seem to die more often within the first year and have less chance of being fitted with a prosthesis. Poor walkers, older than 75, with diabetes mellitus and a transfemoral amputation seem to stay more often in a nursing home after one year. DISCUSSION: Although the results are largely comparable with other studies, there appear to be differences in age, amputation level and course and duration of treatment. The predicting factors found here may help the rehabilitation specialist in advising on the best moment and level of amputation and course of treatment.


Subject(s)
Amputation, Surgical/rehabilitation , Patient Care/statistics & numerical data , Rehabilitation Centers/organization & administration , Activities of Daily Living , Adult , Age Distribution , Aged , Aged, 80 and over , Ambulatory Care/organization & administration , Amputation, Surgical/economics , Amputation, Surgical/mortality , Appointments and Schedules , Cohort Studies , Female , Follow-Up Studies , Health Care Costs , Humans , Incidence , Leg , Length of Stay/statistics & numerical data , Logistic Models , Male , Middle Aged , Netherlands , Nursing Homes , Postoperative Complications/economics , Postoperative Complications/rehabilitation , Retrospective Studies , Risk Factors , Sex Distribution , Survival Rate
3.
Neth J Med ; 42(3-4): 93-8, 1993 Apr.
Article in English | MEDLINE | ID: mdl-8316330

ABSTRACT

To determine whether young patients who suffered a stroke in the past, have a higher prevalence of ACA of LAC as compared to healthy controls, we evaluated 44 stroke patients and 46 controls in a case-control study for the presence of ACA and LAC. All the patients had had a stroke under the age of 50 yr and the stroke date was less than 5 yr ago (mean 2.5 yr). Stroke was defined as an ischaemic cerebral infarction and was confirmed by angiography, CT-scan or MRI. An age- and sex-matched group of healthy volunteers served as controls. The mean age of the patients was 41.4 yr (range 22-52 yr), and of the controls 36.8 yr (range 24-50 yr). Serum and plasma from both groups was examined for IgM- and IgG-ACA and LAC. One patient was positive for both IgG- and IgM-ACA, whereas 3 controls were found positive for IgG-ACA. For 2 patients and 5 controls an equivocal result was obtained for IgG-ACA or IgM-ACA. None of the patients or controls were positive for LAC. The differences between the patient and control group were statistically not significant. In conclusion, no difference was found in the prevalence of cardiolipin antibodies in sera from patients with a stroke within the last 5 yr and an age- and sex-matched control group. There was no correlation either between the presence of lupus anticoagulant and the occurrence of a stroke in the past.


Subject(s)
Antibodies, Anticardiolipin/blood , Cerebrovascular Disorders/blood , Lupus Coagulation Inhibitor/blood , Adult , Antibodies, Anticardiolipin/immunology , Case-Control Studies , Cerebrovascular Disorders/immunology , Female , Humans , Immunoglobulin G/blood , Immunoglobulin M/blood , Lupus Coagulation Inhibitor/immunology , Male , Middle Aged , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...